Peptides have become a favourite word on premium skincare labels, wrapped in the language of "signalling" and "rebuilding". They are a legitimate category of ingredient, but they also sit in a zone where marketing tends to sprint ahead of the evidence. A calm, sceptical look helps separate the useful from the oversold.
The honest summary: promising, plausible, and not the miracle the packaging implies.
What peptides are
Peptides are short chains of amino acids — the same building blocks that make up proteins like collagen in the skin. The theory behind their use in skincare is that certain peptides can act as messengers, signalling skin cells to behave in helpful ways, such as supporting the skin’s own repair and firmness processes.
It is a reasonable biological idea, and some peptides have supportive research behind them. The category is not snake oil.
Where the hype outruns proof
The complication is that "peptides" is a huge, varied family, and the evidence for any specific peptide in a specific product at a specific concentration is often thin. A label boasting peptides tells you little about whether that particular formula does anything meaningful. Marketing frequently borrows the credibility of the category to sell products with no proven benefit.
They are also usually positioned as gentle, supportive ingredients rather than powerhouse actives, so expectations of dramatic change are misplaced regardless.
A sensible stance
Peptides are a fine, low-risk addition to a routine, and some may offer modest supportive benefits over time. But they should not command a huge premium on the strength of the word alone, nor replace the ingredients with stronger evidence behind them.
Treat a peptide product as a pleasant supporting player: welcome if it fits your budget and suits your skin, but not something to build your whole routine — or your hopes — around.
What a peptide actually is
A peptide is a short chain of amino acids — the same building blocks that make proteins, joined by the same bonds, but far shorter. Proteins run to hundreds or thousands of amino acids; the peptides used in skincare are typically between two and ten.
That length is not incidental. Collagen is a protein far too large to penetrate skin, but fragments of collagen are small enough to get somewhere, and the entire premise of peptide skincare rests on that difference.
The biological logic is that fragments of a protein can act as signals. When collagen breaks down, specific fragments are released, and the theory is that fibroblasts read those fragments as evidence of damage and respond by synthesising more collagen.
Applying such fragments topically would then amount to sending a repair signal without the damage. That is a genuinely elegant idea, and how well it works in practice is the whole question.
The four families you will encounter
Signal peptides are the largest group and include the palmitoyl pentapeptides marketed as Matrixyl. They are intended to stimulate collagen, elastin and glycosaminoglycan production by acting as the fragments described above.
Carrier peptides deliver trace elements to the skin, most commonly copper. Copper tripeptide-1 has been studied for wound healing and has a longer research history than most ingredients in this category.
Neurotransmitter-inhibiting peptides — acetyl hexapeptide-8, sold as Argireline, is the best known — are intended to interfere with the signalling that causes muscle contraction, on a mechanism loosely analogous to botulinum toxin.
Enzyme-inhibiting peptides work by blocking the matrix metalloproteinases that break collagen down, which is a preventive rather than a constructive mechanism and is arguably the most plausible of the four.
The penetration problem
Peptides are still fairly large by the standards of topical delivery, and they are hydrophilic, which the lipid-rich stratum corneum is specifically designed to exclude. Getting them past the outer layer in useful quantity is not straightforward.
Formulators address this by attaching a fatty acid chain — the palmitoyl prefix on so many peptide names — which makes the molecule more lipophilic and improves penetration. This is a genuine technical solution rather than a marketing flourish.
Even so, the quantity reaching the dermis where fibroblasts live is uncertain and rarely quantified in the materials that accompany a product. Most published penetration data comes from the ingredient supplier.
This is the central weakness of the category. The mechanism is plausible, the delivery is difficult, and the step between the two is where most of the uncertainty sits.
What the evidence actually shows
For copper peptides in wound healing, the evidence is reasonable and predates the cosmetic interest. For cosmetic anti-ageing outcomes it is thinner, and the studies are mostly small.
For Matrixyl and similar signal peptides, several studies report measurable improvements in wrinkle depth and skin firmness. Almost all of them are small, short, and conducted or funded by the companies that sell the ingredient, which is not disqualifying and is worth knowing.
For Argireline, the studies report reductions in wrinkle depth of the order of twenty to thirty per cent in some measures. Independent replication is limited, and the comparison to injectable botulinum toxin that appears in marketing is not supported by anything in the data.
The honest overall summary: peptides probably do something, the effect is modest, the evidence is weaker than for retinoids or sunscreen by a wide margin, and the field has a funding problem it has not resolved.
Where the hype outruns the proof
Botox in a bottle is the claim that most clearly exceeds the evidence. Injectable botulinum toxin is placed directly into muscle and blocks neuromuscular transmission; a topical peptide applied to the skin surface faces the entire barrier before reaching anything relevant.
Proprietary complexes with trademarked names and no published data are the second category to treat sceptically. A name is not a mechanism, and a complex that has never been described in a journal is being sold on branding.
Percentage claims are frequently meaningless here, because many peptide ingredients are supplied as dilute solutions. Five per cent of a supplier's blend that is itself mostly water and glycerin is not five per cent peptide.
And the position on the ingredient list matters as much as anywhere. Peptides appearing after the preservative are present at trace level, which describes a substantial fraction of the products sold on them.
Where peptides are genuinely useful
They are extremely well tolerated. Unlike retinoids and acids, peptides essentially do not irritate, do not increase sun sensitivity, and can be used morning and evening without a tolerance-building period.
That makes them a reasonable option for people who cannot use the better-evidenced actives — during pregnancy, on rosacea-prone skin, during a barrier recovery period, or for anybody who has tried retinoids repeatedly and cannot tolerate them.
They also combine freely with almost everything, which cannot be said of most actives. There is no meaningful conflict between peptides and niacinamide, hyaluronic acid, ceramides or sunscreen.
And in a moisturiser, where the base formulation is doing useful work regardless, a peptide inclusion costs nothing. If the cream would be good anyway, the peptides are a free option rather than a premium worth paying.
The old copper peptide controversy
For years the advice circulated that copper peptides and vitamin C must never be used together, on the reasoning that ascorbic acid would reduce the copper and destabilise both.
The underlying chemistry is not imaginary — copper ions do catalyse the oxidation of ascorbic acid — but the concern is largely theoretical in well-formulated products at the concentrations used, and the practical evidence for harm is thin.
The straightforward resolution is separation by time of day, which most routines do anyway: vitamin C in the morning, peptides at night. This costs nothing and sidesteps the question entirely.
It is a useful example of how a plausible mechanism can generate a rule that outlives the evidence for it, which happens frequently in this field and is worth being alert to.
A sensible position on the category
Do not build a routine around peptides. The ingredients with strong evidence — sunscreen, retinoids, and for pigmentation the tyrosinase inhibitors — should be established first, because the gap in evidence quality between those and peptides is large.
Do not pay a premium for them. A well-formulated moisturiser containing peptides is a reasonable purchase; a peptide serum at four times the price of a good moisturiser is buying a story.
Do consider them if the better options are unavailable to you, whether through pregnancy, intolerance or a barrier that cannot currently take an active. In that situation a peptide product is a genuinely reasonable thing to be using.
And judge results over months rather than weeks, with a photograph taken at the start, because the effect if present is modest enough that memory is not a reliable instrument for detecting it.
Reading a peptide label
Look for named peptides rather than complexes. Palmitoyl pentapeptide-4, palmitoyl tripeptide-1, acetyl hexapeptide-8 and copper tripeptide-1 are specific molecules with literature attached. A trademarked complex may contain any of these or none.
Check the position. Above the preservative means present at some concentration; below it means trace. This single check disqualifies a surprising number of products marketed primarily on their peptide content.
Prefer products where the peptides sit alongside ingredients that are doing reliable work anyway — glycerin, ceramides, niacinamide — so that the product is worth using even if the peptides contribute nothing.
And treat elaborate mechanism explanations on packaging with the same scepticism as elsewhere. The mechanism is not in dispute; whether enough of the molecule arrives to act on it is, and no amount of diagram addresses that.
How the category compares on evidence
A rough hierarchy is useful here. Sunscreen sits at the top, with decades of evidence for preventing photoageing, pigmentation and cancer. Retinoids come next, with biopsy-confirmed collagen synthesis and a very large literature.
Below those sit the well-studied specifics: azelaic acid for redness and pigmentation, niacinamide for barrier function and tone, alpha hydroxy acids for texture, vitamin C for antioxidant support. Each has independent research and a defined mechanism.
Peptides sit below that group. The mechanisms are plausible, the studies exist, and the studies are mostly small and mostly funded by ingredient suppliers. That is not the same as no evidence and it is not the same as good evidence.
Below peptides sit stem cell extracts, growth factors in cosmetic products, and most proprietary complexes, where the evidence thins to almost nothing. Knowing roughly where a category sits on that ladder is more useful than any individual product review.
The one-paragraph verdict
Peptides are not a scam and they are not a breakthrough. They are a plausible mechanism with modest, mostly industry-funded evidence, delivered through a barrier that was designed to keep molecules like them out.
They are exceptionally well tolerated, which is their strongest practical argument. For anybody who cannot use retinoids — during pregnancy, on reactive skin, during barrier recovery — a peptide product is a reasonable thing to be using rather than nothing.
For everybody else, they belong after sunscreen and a retinoid rather than instead of either, and they are worth having in a moisturiser rather than paying a premium for in a serum.